rifampicin
PolandDrugs containing this active substance
-
The medicine is used to treat pulmonary and extrapulmonary tuberculosis, in both newly diagnosed cases and in cases of disease recurrence.
Form: capsules, hard
Active substance Dosage rifampicin 300 mg isoniazid 150 mg ATC: J04AM02
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
The medicine is used to treat pulmonary and extrapulmonary tuberculosis (both in newly diagnosed cases and relapses), provided that the bacteria causing the disease are sensitive to the substances contained therein.
Form: capsules, hard
Active substance Dosage rifampicin 150 mg isoniazid 100 mg ATC: J04AM02
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
This is an antibiotic used in the treatment of tuberculosis, leprosy, brucellosis, legionellosis, and severe staphylococcal infections. It may also be used to prevent meningococcal meningitis and infections caused by the Haemophilus influenzae bacterium.
Form: capsules, hard
Active substance Dosage rifampicin 150 mg ATC: J04AB02
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.
-
This is an antibiotic used in the treatment of tuberculosis, leprosy, brucellosis, legionellosis, and severe staphylococcal infections. It may also be used to prevent meningococcal meningitis and infections caused by Haemophilus influenzae.
Form: capsules, hard
Active substance Dosage rifampicin 300 mg ATC: J04AB02
Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.